Literature DB >> 16730722

Relaxin has a role in establishing a renal response in pregnancy.

Marie C Smith1, Alison P Murdoch, Lee A Danielson, Kirk P Conrad, John M Davison.   

Abstract

Women with normal ovarian function (n = 9) and women who conceived with ovum donation (no circulating relaxin; n = 9) had serial measurements of renal function made during the first trimester of pregnancy by using 24-hour creatinine clearance (CrCl) and plasma osmolality (P(osm)). All pregnancies were associated with increasing CrCl and reduced P(osm), but the change from baseline was significantly greater in the women with normal ovarian function, indicating that in contrast to the rodent model, other factors in addition to circulating relaxin contribute to gestational renal adaptation to human pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730722     DOI: 10.1016/j.fertnstert.2005.11.070

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  22 in total

Review 1.  Effects of relaxin on arterial dilation, remodeling, and mechanical properties.

Authors:  Kirk P Conrad; Sanjeev G Shroff
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

Review 2.  Plasticity of the Maternal Vasculature During Pregnancy.

Authors:  George Osol; Nga Ling Ko; Maurizio Mandalà
Journal:  Annu Rev Physiol       Date:  2019-02-10       Impact factor: 19.318

Review 3.  Maternal vasodilation in pregnancy: the emerging role of relaxin.

Authors:  Kirk P Conrad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-25       Impact factor: 3.619

Review 4.  Vascular actions of relaxin: nitric oxide and beyond.

Authors:  C H Leo; M Jelinic; H H Ng; S A Marshall; J Novak; M Tare; K P Conrad; L J Parry
Journal:  Br J Pharmacol       Date:  2016-09-30       Impact factor: 8.739

5.  GPCRs as potential therapeutic targets in preeclampsia.

Authors:  Jt McGuane; Kp Conrad
Journal:  Drug Discov Today Dis Models       Date:  2012-07-12

6.  Maternal Cardiovascular Dysregulation During Early Pregnancy After In Vitro Fertilization Cycles in the Absence of a Corpus Luteum.

Authors:  Kirk P Conrad; John W Petersen; Yueh-Yun Chi; Xiaoman Zhai; Minjie Li; Kuei-Hsun Chiu; Jing Liu; Melissa D Lingis; R Stan Williams; Alice Rhoton-Vlasak; Joseph J Larocca; Wilmer W Nichols; Mark S Segal
Journal:  Hypertension       Date:  2019-07-29       Impact factor: 10.190

Review 7.  Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia.

Authors:  Kirk P Conrad
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

Review 8.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

9.  Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities?

Authors:  Ilknur Inegol Gumus; Ebru Uz; Nuket Bavbek; Ayse Kargili; Burcu Yanik; Faruk Hilmi Turgut; Ali Akcay; Nilgun Ozturk Turhan
Journal:  Int Urol Nephrol       Date:  2009-07-04       Impact factor: 2.370

10.  Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies.

Authors:  Kirk P Conrad; Valerie L Baker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-24       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.